Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Calcif Tissue Int. 2014 Apr 4;94(6):659–664. doi: 10.1007/s00223-014-9849-4

Table 2.

Comparison of treatment rates for bisphosphonate and calcium/vitamin D between intervention and control facilities.

Intervention Facilities Control Facilities
All clinical fractures
Baseline Follow-up P Baseline Follow-up P P*
N=900 N=1062 N=599 N=520
Bisphosphonate 43 (4.8%) 78 (7.3%) 0.02 37 (6.2%) 23 (4.4%) 0.23 0.02
CA and/or Vit. D 192 (21.3%) 374 (35.2%) <0.01 213 (35.6%) 179 (34.4%) 0.71 <0.01
Major osteoporotic fractures
Baseline Follow-up Baseline Follow-up
N=249 N=309 N=163 N=162
Bisphosphonate 19 (7.6%) 35 (11.3%) 0.15 14 (8.6%) 11 (6.8%) 0.68 0.18
CA and/or Vit. D 69 (27.7%) 132 (42.7%) <0.01 64 (39.3%) 64 (39.5%) 1.00 0.02

P compares treatment rates before and after implementation of the E-consult service within facilities group

*

P compares treatment rates between intervention and control facilities